Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Clinical Investigation to Compare Orlistat 60 mg and a Customized Polyglucosamine, Two Treatment Methods for the Management of Overweight and Obesity

NCT02529631 is registered in ClinicalTrials.gov with Certmedica International GmbH as lead sponsor.

NCT NCT02529631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02529631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Clinical Investigation to Compare Orlistat 60 mg and a Customized Polyglucosamine, Two Treatment Methods for the Management of Overweight and Obesity
Lead sponsor
Certmedica International GmbH
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2009
Completion date
August 31, 2013
Enrollment
64 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight